erythromycin has been researched along with alemcinal in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, CM; Faghih, R; Freiberg, L; Klein, LL; Lartey, PA; Marsh, K; Nellans, HN; Petersen, A; Plattner, JJ; Quigley, S | 1 |
| Bennani, YL; Faghih, R; Lartey, PA; Marsh, K; Nellans, HN; Petersen, A; Plattner, JJ | 1 |
| Burgeon, E; Carreras, C; Depoortere, I; Liu, Y; Peeters, TL; Perret, J; Robberecht, P; Thielemans, L; Thijs, T | 1 |
| Geypens, BJ; Ghoos, YF; Maes, B; Samsom, M; Smout, AJ; Verhagen, MA | 1 |
| Bertrand, PP; Bornstein, JC; Clark, MJ; Furness, JB; Verlinden, M; Wright, T | 1 |
| Bertrand, PP; Bornstein, JC; Clark, MJ; Furness, JB; Jenkinson, KM; Verlinden, M; Wright, T | 1 |
| Akkermans, LM; Gooszen, HG; Nieuwenhuijs, VB; van Duijvenbode-Beumer, H; Verheem, A; Verhoef, J; Visser, MR | 1 |
| Samsom, M; Smout, AJ; Van Herwaarden, MA; Van Nispen, CH; Verlinden, M | 1 |
| Gonzalez, A; Ryan, RP; Sarna, SK | 1 |
| Besecke, LM; Cowles, VE; Faghih, R; Mohning, KM; Nellans, HN; Segreti, JA; Seifert, TR; Verlinden, MH; Wegner, CD | 1 |
| Beker, JA; Brinkhoff, H; Dettmer, A; Ducrotte, P; Eaker, E; Fumagalli, I; Mack, RJ; Mathias, JR; Miner, PB; Ohning, G; Snape, W; Staessen, D; Talley, NJ; Verlinden, M | 1 |
| Geenen, DJ; Hogan, RB; Mack, RJ; McCallum, RW; Riff, D; Talley, NJ; Verlinden, M | 1 |
| Brinkhoff, H; Chen, CL; Dettmer, A; Krause, R; Lanza, F; Mack, RJ; Orr, WC; Riff, D; Schwartz, S; Soloway, RD; Verlinden, MH | 1 |
| Inauen, W; Netzer, P; Schmitt, B | 1 |
| Camilleri, M | 1 |
| Itoh, Z; Koga, H; Omura, S; Ozaki, K; Takanashi, H; Yogo, K | 1 |
| Depoortere, I; Mitselos, A; Peeters, TL; Vanden Berghe, P | 1 |
| Jiang, X; Lan, L; Liu, L; Sun, Y; Wang, BX; Wang, CH; Wang, LC | 1 |
| Nong, L; Qin, S; Tang, Y; Wang, J; Wei, Y; Zhou, Y | 1 |
| Bollegala, NP; Khanna, R; Leontiadis, GI; Moayyedi, P; Pittayanon, R; Yuan, Y | 1 |
1 review(s) available for erythromycin and alemcinal
| Article | Year |
|---|---|
Prokinetics for functional dyspepsia.
Topics: Benzamides; Benzyl Compounds; Cisapride; Domperidone; Dyspepsia; Erythromycin; Gastrointestinal Agents; Humans; Indoles; Morpholines; Numbers Needed To Treat; Quality of Life; Randomized Controlled Trials as Topic; Thiazoles | 2018 |
6 trial(s) available for erythromycin and alemcinal
| Article | Year |
|---|---|
Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers.
Topics: Administration, Oral; Adult; Cross-Over Studies; Double-Blind Method; Duodenum; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Male; Manometry; Motilin; Postprandial Period; Reference Values | 1997 |
The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients.
Topics: Adult; Cisapride; Cross-Over Studies; Double-Blind Method; Erythromycin; Esophagus; Female; Gastroesophageal Reflux; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Motilin | 2000 |
Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.
Topics: Adult; Aged; Double-Blind Method; Dyspepsia; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Helicobacter pylori; Humans; Male; Middle Aged; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide | 2000 |
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Breath Tests; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Gastroparesis; Humans; Male; Middle Aged; Motilin; Regression Analysis; Treatment Outcome | 2001 |
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Gastroesophageal Reflux; Humans; Male; Quality of Life; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Surveys and Questionnaires; Treatment Outcome | 2002 |
Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease.
Topics: Adult; Aged; Aged, 80 and over; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Gastric Emptying; Gastroesophageal Reflux; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Motilin | 2002 |
13 other study(ies) available for erythromycin and alemcinal
| Article | Year |
|---|---|
Synthesis of 4"-deoxy motilides: identification of a potent and orally active prokinetic drug candidate.
Topics: Administration, Oral; Animals; Biological Availability; Dogs; Erythromycin; Female; Gastrointestinal Motility; In Vitro Techniques; Male; Muscle, Smooth; Rabbits | 1995 |
Preparation of 9-deoxo-4"-deoxy-6,9-epoxyerythromycin lactams "motilactides": potent and orally active prokinetic agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Dogs; Epoxy Compounds; Erythromycin; Indicators and Reagents; Molecular Structure; Myoelectric Complex, Migrating; Prodrugs; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Structure-Activity Relationship | 1998 |
Desensitization of the human motilin receptor by motilides.
Topics: Animals; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Erythromycin; Humans; Muscle Contraction; Radioligand Assay; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Structure-Activity Relationship | 2005 |
An action of erythromycin in the intestine that is not mediated via motilin receptors.
Topics: Animals; Dose-Response Relationship, Drug; Erythromycin; Female; Gastrointestinal Agents; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Intestines; Male; Muscle Contraction; Rabbits; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Swine | 1999 |
Erythromycin derivatives ABT 229 and GM 611 act on motilin receptors in the rabbit duodenum.
Topics: Animals; Anti-Bacterial Agents; Carbachol; Dose-Response Relationship, Drug; Duodenum; Erythromycin; Female; Gastrointestinal Agents; Male; Motilin; Muscle Contraction; Rabbits; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide | 1999 |
The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats.
Topics: Animals; Drug Interactions; Duodenum; Erythromycin; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Ileum; Intestine, Small; Male; Morphine; Octreotide; Rats; Rats, Sprague-Dawley | 1999 |
Enteric locus of action of prokinetics: ABT-229, motilin, and erythromycin.
Topics: Animals; Atropine; Cell Size; Cells, Cultured; Dogs; Duodenum; Electric Stimulation; Erythromycin; Female; Gastrointestinal Agents; Gastrointestinal Motility; Hexamethonium; In Vitro Techniques; Infusions, Intra-Arterial; Intestinal Mucosa; Jejunum; Male; Methacholine Chloride; Motilin; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Rabbits; Stomach; Tetrodotoxin | 2000 |
Effect of novel motilide ABT-229 versus erythromycin and cisapride on gastric emptying in dogs.
Topics: Animals; Cisapride; Dogs; Dose-Response Relationship, Drug; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Gastrointestinal Motility; Muscle Contraction | 2000 |
Motilin agonists and dyspepsia: throwing out the baby with the bath water.
Topics: Dyspepsia; Erythromycin; Gastric Emptying; Humans; Motilin | 2002 |
In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine.
Topics: Acetylcholine; Animals; Atropine; Binding, Competitive; Calcium Chloride; Diltiazem; Dose-Response Relationship, Drug; Erythromycin; Hexamethonium; Hydrogen-Ion Concentration; In Vitro Techniques; Indoles; Intestine, Small; Male; Molecular Structure; Muscle Contraction; Muscle, Smooth; Naloxone; Rabbits; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Tetrodotoxin; Tropisetron; Verapamil | 2007 |
Differences in motilin receptor desensitization after stimulation with motilin or motilides are due to alternative receptor trafficking.
Topics: Animals; Arrestins; beta-Arrestin 1; beta-Arrestin 2; beta-Arrestins; CHO Cells; Cricetinae; Cricetulus; Erythromycin; Humans; Motilin; Phosphorylation; Protein Transport; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Transfection | 2008 |
[Effect of interstitial cells of Cajal on gastrointestinal motility induced by motilin receptor agonist ABT-229].
Topics: Animals; Erythromycin; Female; Gastrointestinal Motility; Interstitial Cells of Cajal; Male; Rabbits; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide | 2010 |
Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
Topics: Adult; Carcinoma; Case-Control Studies; Erythromycin; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Osteopontin; Polymorphism, Genetic | 2014 |